{"id":"W2889986295","doi":"10.1200/jco.2017.35.15_suppl.e15007","title":"Real world eligibility of treatment-refractory stage IV colorectal cancer patients for palliative intent regorafenib monotherapy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); University of British Columbia","funders":"","keywords":"Medicine; Regorafenib; Internal medicine; Panitumumab; Colorectal cancer; Cetuximab; Refractory (planetary science); Oncology; Performance status; Cancer; Stage (stratigraphy)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009673628,0.0001689441,0.000542032,0.0004771836,0.0004892612,0.0007913731,0.0005670149,0.0008253028,0.004066102],"category_scores_gemma":[0.02093374,0.0002202987,0.0005709814,0.0007223375,0.0005216895,0.0005115901,0.000709758,0.0004886166,0.0007855801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001050622,"about_ca_system_score_gemma":0.001665439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002447712,"about_ca_topic_score_gemma":0.005597466,"domain_scores_codex":[0.9932741,0.004380113,0.0008021229,0.0005934222,0.0006142522,0.0003360258],"domain_scores_gemma":[0.9795386,0.009190082,0.008273227,0.00110638,0.001036314,0.0008553073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03415317,0.000748982,0.8971681,0.001085381,0.0003000023,0.0006466389,0.0005074644,0.0007034159,0.001056106,0.000753267,0.01333481,0.04954259],"study_design_scores_gemma":[0.008628806,0.007141831,0.9534715,0.0006222776,0.0004820039,0.002101864,0.0006813057,0.003004187,0.001329029,0.0009036514,0.02155367,0.00007994643],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857244,0.001415957,0.0004841938,0.0010161,0.00004873033,0.00117787,0.006565684,0.00001710415,0.003550029],"genre_scores_gemma":[0.9921227,0.0002410374,0.0008743135,0.0007127732,0.00004800584,0.001229049,0.004334438,0.000006370895,0.0004313428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009673628,"threshold_uncertainty_score":0.05115962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1896415069196408,"score_gpt":0.53253625672663,"score_spread":0.3428947498069892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}